Patents by Inventor Steven A. Enkemann

Steven A. Enkemann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Molecular imaging of cancer cells in vivo
    Patent number: 11077212
    Abstract: Cellular targets on cancer cells have been identified that can be used with targeted molecular imaging to detect the cancer cells in vivo. Non-invasive methods for detecting cancer cells, such as metastasized cancer cells, are therefore provided. Also provided are compositions and kits for use in the disclosed methods.
    Type: Grant
    Filed: August 24, 2011
    Date of Patent: August 3, 2021
    Assignee: H. Lee Moffitt Cancer Center and Research Institute, Inc.
    Inventors: David L. Morse, Robert J. Gillies, William Bradford Carter, Narges K. Tafreshi, Marilyn M. Bui, Steven A. Enkemann
  • Gene signature for the prediction of NF-kappaB activity
    Patent number: 9115388
    Abstract: Methods for predicting NF-kappaB (NF-kB) activity in a tumor, and more particularly to methods for predicting survival and therapeutic outcome, and selecting therapy in subjects with tumors, e.g., adenocarcinomas, e.g., lung adenocarcinomas and melanomas.
    Type: Grant
    Filed: November 1, 2012
    Date of Patent: August 25, 2015
    Assignee: H. Lee Moffitt Cancer Center and Research Institute, Inc.
    Inventors: Amer A. Beg, Steven A. Enkemann, Dung-Tsa Chen
  • Gene Signature for the Prediction of NF-kappaB Activity
    Publication number: 20140302060
    Abstract: Methods for predicting NF-kappaB (NF-kB) activity in a tumor, and more particularly to methods for predicting survival and therapeutic outcome, and selecting therapy in subjects with tumors, e.g., adenocarcinomas, e.g., lung adenocarcinomas and melanomas.
    Type: Application
    Filed: November 1, 2012
    Publication date: October 9, 2014
    Applicant: H. Lee Moffitt Cancer and Research Institute, Inc.
    Inventors: Amer A. Beg, Steven A. Enkemann, Dung-Tsa Chen
  • Molecular Imaging of Cancer Cells In Vivo
    Publication number: 20130129619
    Abstract: Cellular targets on cancer cells have been identified that can be used with targeted molecular imaging to detect the cancer cells in vivo. Non-invasive methods for detecting cancer cells, such as metastasized cancer cells, are therefore provided. Also provided are compositions and kits for use in the disclosed methods.
    Type: Application
    Filed: August 24, 2011
    Publication date: May 23, 2013
    Applicant: H. Lee Moffitt Cancer Center and Research Institute, Inc.
    Inventors: David L. Morse, Robert J. Gillies, William Bradford Carter, Narges K. Tafreshi, Marilyn M. Bui, Steven A. Enkemann